Tumor-derived EVs (TDEVs), secreted by cancer cells in their microenvironmental niches, carry oncogenic proteins, oxidative stressors like Nrf2 inhibitors, and miRNAs that repress antioxidant pathways in target cells to induce tumor growth by promoting oxidative DNA damage and evading immune cells [155]. The gene discussed is PROS1; the disease is neoplasm.